Trials of the experimental drug EMA401 found it cut pain levels by at least 30 per cent for more than half of sufferers - some of whom had been in agony for years.
from Health | Mail Online http://ift.tt/1aqMq0N
via dailymail
from Health | Mail Online http://ift.tt/1aqMq0N
via dailymail
No comments:
Post a Comment